Weekly Spotlight - 27.11.24

Anastrozole Boosts Height in Children with Adrenal Disorder

Subscribe | Follow us on LinkedIn đź”—

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Anastrozole Boosts Height in Children with Adrenal Disorder

Anastrozole, a medication typically used for breast cancer, has been found to increase height in children with congenital adrenal hyperplasia (CAH) by reducing androgen levels, which can help manage growth issues associated with the condition. This treatment shows promise in improving the quality of life for these children.

FDA Approves BridgeBio Pharma's Attr-CM Treatment, Atrurby (Acoramidis) for Rare Heart Condition

BridgeBio Pharma has received FDA approval for ATRUBY (acoramidis), a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM). This approval highlights advancements in rare disease treatments from BridgeBio Pharma, which could inspire hope for similar breakthroughs in other conditions which they cover, such as congenital adrenal hyperplasia.

Health Spotlight’s Congenital Adrenal Hyperplasia is a Contentive publication in the Healthcare division